Jonathan Z Li

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. ncbi Efficacy of short-course antibiotic regimens for community-acquired pneumonia: a meta-analysis
    Jonathan Z Li
    Department of Medicine, San Francisco VA Medical Center, University of California, San Francisco, CA 94143 0862, USA
    Am J Med 120:783-90. 2007
  2. ncbi Ocular syphilis among HIV-infected individuals
    Jonathan Z Li
    Division of Infectious Diseases, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Clin Infect Dis 51:468-71. 2010
  3. ncbi Prevalence and significance of HIV-1 drug resistance mutations among patients on antiretroviral therapy with detectable low-level viremia
    Jonathan Z Li
    Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
    Antimicrob Agents Chemother 56:5998-6000. 2012
  4. ncbi Impact of minority nonnucleoside reverse transcriptase inhibitor resistance mutations on resistance genotype after virologic failure
    Jonathan Z Li
    Division of Infectious Diseases, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
    J Infect Dis 207:893-7. 2013
  5. ncbi Evaluation of HIV-1 ambiguous nucleotide frequency during antiretroviral treatment interruption
    Jonathan Z Li
    Division of Infectious Diseases, Brigham and Women s Hospital, 65 Landsdowne Street, Room 435, Cambridge, MA, USA
    J Acquir Immune Defic Syndr 61:19-22. 2012
  6. ncbi Characteristics and outcomes of initial virologic suppressors during analytic treatment interruption in a therapeutic HIV-1 gag vaccine trial
    Jonathan Z Li
    Division of Infectious Diseases, Brigham and Women s Hospital, Boston, Massachusetts, United States of America
    PLoS ONE 7:e34134. 2012
  7. ncbi Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failure
    Jonathan Z Li
    Division of Infectious Diseases, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
    AIDS 26:185-92. 2012
  8. ncbi Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis
    Jonathan Z Li
    Section of Retroviral Therapeutics, Brigham and Women s Hospital, Harvard Medical School, Harvard University, Boston, Massachusetts 02139, USA
    JAMA 305:1327-35. 2011
  9. ncbi Factors associated with viral rebound in HIV-1-infected individuals enrolled in a therapeutic HIV-1 gag vaccine trial
    Jonathan Z Li
    Section of Retroviral Therapeutics, Brigham and Women s Hospital, Boston, Massachusetts 02139, USA
    J Infect Dis 203:976-83. 2011
  10. ncbi Ocular syphilis among HIV-infected patients: a systematic analysis of the literature
    Joseph D Tucker
    Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, 55 Fruit Street, GRJ 504, Boston 02114, USA
    Sex Transm Infect 87:4-8. 2011

Detail Information

Publications14

  1. ncbi Efficacy of short-course antibiotic regimens for community-acquired pneumonia: a meta-analysis
    Jonathan Z Li
    Department of Medicine, San Francisco VA Medical Center, University of California, San Francisco, CA 94143 0862, USA
    Am J Med 120:783-90. 2007
    ..The goal of this study is to systematically review randomized controlled trials comparing short-course and extended-course antibiotic regimens for community-acquired pneumonia...
  2. ncbi Ocular syphilis among HIV-infected individuals
    Jonathan Z Li
    Division of Infectious Diseases, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Clin Infect Dis 51:468-71. 2010
    ..5 years. In patients with HIV infection, clinicians should be vigilant for ocular syphilis despite normal cerebrospinal fluid measures and for syphilis reinfection...
  3. ncbi Prevalence and significance of HIV-1 drug resistance mutations among patients on antiretroviral therapy with detectable low-level viremia
    Jonathan Z Li
    Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
    Antimicrob Agents Chemother 56:5998-6000. 2012
    ..Virologic failure followed 16% of LLV time points. Strategies for early intervention after LLV episodes should be further studied...
  4. ncbi Impact of minority nonnucleoside reverse transcriptase inhibitor resistance mutations on resistance genotype after virologic failure
    Jonathan Z Li
    Division of Infectious Diseases, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
    J Infect Dis 207:893-7. 2013
    ..NNRTI regimen choice and preexisting NNRTI-resistant minority variants were both associated with the probability and type of resistance mutations detected after virologic failure...
  5. ncbi Evaluation of HIV-1 ambiguous nucleotide frequency during antiretroviral treatment interruption
    Jonathan Z Li
    Division of Infectious Diseases, Brigham and Women s Hospital, 65 Landsdowne Street, Room 435, Cambridge, MA, USA
    J Acquir Immune Defic Syndr 61:19-22. 2012
    ..Increased HIV diversity during the ATI may represent a potentially higher barrier to success for a therapeutic as compared with a preventative vaccine targeting cell-mediated immunity...
  6. ncbi Characteristics and outcomes of initial virologic suppressors during analytic treatment interruption in a therapeutic HIV-1 gag vaccine trial
    Jonathan Z Li
    Division of Infectious Diseases, Brigham and Women s Hospital, Boston, Massachusetts, United States of America
    PLoS ONE 7:e34134. 2012
    ..In the placebo-controlled trial ACTG A5197, a trend favoring viral suppression was seen in the HIV-1-infected subjects who received a recombinant Ad5 HIV-1 gag vaccine...
  7. ncbi Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failure
    Jonathan Z Li
    Division of Infectious Diseases, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
    AIDS 26:185-92. 2012
    ..To evaluate the risk of virologic failure conferred by suboptimal adherence to nonnucleoside reverse transcriptase inhibitors (NNRTIs) and minority NNRTI resistance mutations...
  8. ncbi Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis
    Jonathan Z Li
    Section of Retroviral Therapeutics, Brigham and Women s Hospital, Harvard Medical School, Harvard University, Boston, Massachusetts 02139, USA
    JAMA 305:1327-35. 2011
    ....
  9. ncbi Factors associated with viral rebound in HIV-1-infected individuals enrolled in a therapeutic HIV-1 gag vaccine trial
    Jonathan Z Li
    Section of Retroviral Therapeutics, Brigham and Women s Hospital, Boston, Massachusetts 02139, USA
    J Infect Dis 203:976-83. 2011
    ..Human immunodeficiency virus type 1 (HIV-1) vaccines directed to the cell-mediated immune system could have a role in lowering the plasma HIV-1 RNA set point, which may reduce infectivity and delay disease progression...
  10. ncbi Ocular syphilis among HIV-infected patients: a systematic analysis of the literature
    Joseph D Tucker
    Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, 55 Fruit Street, GRJ 504, Boston 02114, USA
    Sex Transm Infect 87:4-8. 2011
    ..Objective To examine the literature on HIV-infected patients and determine the results of treatment...
  11. ncbi Low-level detection and quantitation of cellular HIV-1 DNA and 2-LTR circles using droplet digital PCR
    Timothy J Henrich
    Division of Infectious Diseases, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02119, USA
    J Virol Methods 186:68-72. 2012
    ..ddPCR is a promising novel technology for the study of HIV-1 reservoirs and persistence, but further optimization of this novel technology would enhance the detection of very low-level viral genetic targets...
  12. ncbi Predictors of pneumonia severity in HIV-infected adults admitted to an Urban public hospital
    Kara W Chew
    Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine at the University of California, Los Angeles, California 90095, USA
    AIDS Patient Care STDS 25:273-7. 2011
    ..Lack of stable housing was not associated with worse outcomes. The PORT score may be a valid tool to predict mortality and need for hospital admission in HIV-infected patients with CAP...
  13. ncbi Xenotropic murine leukemia virus-related virus prevalence in patients with chronic fatigue syndrome or chronic immunomodulatory conditions
    Timothy J Henrich
    Division of Infectious Diseases, Brigham and Women s Hospital, Boston, Massachusetts, USA
    J Infect Dis 202:1478-81. 2010
    ..XMRV DNA was not detected in any participant samples. We found no association between XMRV and patients with chronic fatigue syndrome or chronic immunomodulatory conditions...
  14. ncbi HSV-1 encephalitis complicated by cerebral hemorrhage in an HIV-positive person
    Jonathan Z Li
    Division of Infectious Diseases, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
    AIDS Read 19:153-5. 2009
    ..He ultimately improved after surgical decompression, treatment with acyclovir, and a switch from a protease inhibitor-based antiretroviral regimen to one including an integrase inhibitor...